Skip to main content
Clinical Trials/NL-OMON44846
NL-OMON44846CompletedNot Applicable

Intraoperative detection of tumor tissue in pancreatic cancer using a VEGF-targeted optical fluorescent imaging tracer - Image guided surgery in pancreatic cancer

niversitair Medisch Centrum Groningen0 sites26 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
26

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • * Age * 18 years.
  • * Patients with clinical suspicion of pancreatic cancer who are scheduled to undergo surgical intervention with curative intent
  • * WHO performance score 0-2.
  • * Signed written informed consent

Exclusion Criteria

  • * Medical or psychiatric conditions that compromise the patient*s ability to give informed consent.
  • * Other invasive malignancy
  • * Pregnant or lactating women. Documentation of a negative pregnancy test must be available for woman of childbearing potential. Woman of childbearing potential are pre- menopausal women with intact reproductive organs and women less than two years after menopause.
  • * Prior neo-adjuvant chemo- of radiotherapy
  • * History of infusion reactions to bevacizumab
  • * Inadequately controlled hypertension with or without current antihypertensive medications
  • * Within 6 months prior to inclusion: myocardial infarction, TIA, CVA pulmonary embolism, uncontrolled chronic hepatic failure, unstable angina pectoris.

Investigators

Similar Trials

Intraoperative detection of tumor tissue... | Clinical Trial